Colchicine in Chronic Kidney Disease Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 744 participants.

Also called NCT06998862

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 744 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06998862
  • EU CT 2023-505868-11-00
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06998862. Randomized; triple masking; primary purpose prevention. Start 2025-02-12 (actual); primary completion 2028-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine in Chronic Kidney Disease Patients
Acronym
COLCHIREN
Condition
Cardiovascular Events
Intervention (Drug)
colchicine treatment in chronic kidney disease patients
Intervention (Drug)
placebo treatment
Lead sponsor
Hospital General Universitario Gregorio Marañon (class: other)

Record details

Record id
cardio:ct-nct06998862
Content hash
04fba0c6df4a29e5e38ceb2207a529837b06be5d67be7ff21dfe2d095e8e8a89